Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Ihab Kamel

Concepts (627)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Neoplasms
118
2024
784
22.230
Why?
Carcinoma, Hepatocellular
71
2024
360
16.800
Why?
Chemoembolization, Therapeutic
42
2024
91
12.830
Why?
Diffusion Magnetic Resonance Imaging
46
2024
153
11.450
Why?
Magnetic Resonance Imaging
137
2025
3566
11.180
Why?
Pancreatic Neoplasms
33
2024
931
6.320
Why?
Cholangiocarcinoma
16
2024
104
5.220
Why?
Contrast Media
57
2025
462
4.840
Why?
Image Enhancement
27
2018
190
4.720
Why?
Tomography, X-Ray Computed
66
2024
2677
4.550
Why?
Carcinoma, Pancreatic Ductal
14
2024
285
4.410
Why?
Image Interpretation, Computer-Assisted
22
2025
267
4.080
Why?
Bile Duct Neoplasms
13
2023
123
4.030
Why?
Liver
38
2025
1938
3.860
Why?
Neuroendocrine Tumors
12
2021
115
3.400
Why?
Liver Cirrhosis
20
2024
316
3.160
Why?
Elasticity Imaging Techniques
9
2023
60
2.970
Why?
Liver Diseases
16
2023
311
2.750
Why?
Pancreatic Cyst
12
2023
60
2.720
Why?
Arrhythmogenic Right Ventricular Dysplasia
16
2022
57
2.610
Why?
Retrospective Studies
101
2025
15564
2.580
Why?
Tumor Burden
13
2024
309
2.520
Why?
Middle Aged
168
2025
33200
2.500
Why?
Gadolinium DTPA
20
2025
70
2.460
Why?
Cholangitis, Sclerosing
4
2020
75
2.390
Why?
Aged
136
2025
23729
2.260
Why?
Algorithms
19
2025
1686
2.250
Why?
Humans
315
2025
136783
2.250
Why?
Cystadenoma, Serous
3
2024
21
2.070
Why?
Pancreatitis
8
2023
132
2.060
Why?
Sensitivity and Specificity
35
2023
1942
1.980
Why?
Male
182
2025
67361
1.920
Why?
Female
193
2025
72840
1.900
Why?
Positron-Emission Tomography
10
2023
295
1.850
Why?
Reproducibility of Results
40
2025
3272
1.850
Why?
Pancreas
13
2024
328
1.810
Why?
Colorectal Neoplasms
10
2021
792
1.690
Why?
Esophageal Neoplasms
12
2024
324
1.630
Why?
Spleen
4
2020
513
1.620
Why?
Carcinoma, Renal Cell
6
2024
214
1.570
Why?
Treatment Outcome
56
2024
10764
1.560
Why?
Adult
112
2025
37616
1.560
Why?
Incidental Findings
5
2024
87
1.550
Why?
Kidney Neoplasms
7
2025
400
1.540
Why?
Splenic Diseases
3
2019
8
1.530
Why?
Cholangiopancreatography, Magnetic Resonance
6
2020
24
1.490
Why?
Iron Overload
4
2024
17
1.460
Why?
Aged, 80 and over
53
2024
7569
1.460
Why?
Diagnosis, Differential
24
2025
1483
1.440
Why?
Embolization, Therapeutic
11
2022
229
1.430
Why?
Adenoma, Liver Cell
4
2024
5
1.430
Why?
Lymphatic Metastasis
5
2024
350
1.280
Why?
Image Processing, Computer-Assisted
16
2025
752
1.270
Why?
Angiomyolipoma
3
2018
24
1.260
Why?
Diagnostic Imaging
14
2024
331
1.240
Why?
Hepatectomy
17
2021
249
1.230
Why?
Ureteral Obstruction
2
2020
64
1.220
Why?
Focal Nodular Hyperplasia
5
2018
8
1.190
Why?
Adipose Tissue
7
2024
629
1.170
Why?
Rectal Neoplasms
6
2024
149
1.170
Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
1683
1.160
Why?
Imaging, Three-Dimensional
14
2018
576
1.160
Why?
Organometallic Compounds
4
2018
111
1.150
Why?
Uterine Neoplasms
4
2023
109
1.150
Why?
Prognosis
26
2024
4018
1.150
Why?
Adenoma
4
2024
230
1.130
Why?
Neoplasm Staging
20
2024
1373
1.120
Why?
Kidney Diseases
3
2020
406
1.100
Why?
ROC Curve
17
2024
545
1.090
Why?
Ultrasonography
5
2024
751
1.040
Why?
Liver Transplantation
14
2025
871
1.030
Why?
Yttrium Radioisotopes
5
2022
57
1.030
Why?
Predictive Value of Tests
23
2024
2030
1.020
Why?
Survival Rate
18
2024
1969
1.010
Why?
Carcinoma
6
2023
236
0.970
Why?
Neoadjuvant Therapy
9
2024
403
0.960
Why?
Magnetic Resonance Angiography
3
2018
240
0.960
Why?
Pneumonia, Viral
2
2020
368
0.950
Why?
Urinary Bladder Neoplasms
7
2022
250
0.950
Why?
Coronavirus Infections
2
2020
359
0.940
Why?
Leiomyoma
3
2023
77
0.930
Why?
Bile Ducts, Intrahepatic
10
2023
78
0.930
Why?
Cardiomyopathy, Hypertrophic
8
2018
142
0.920
Why?
Nomograms
2
2024
54
0.920
Why?
Fibrosis
8
2021
551
0.910
Why?
Neoplasm Grading
6
2024
306
0.910
Why?
Societies, Medical
16
2024
820
0.890
Why?
Adenomyosis
1
2023
4
0.860
Why?
Infusions, Intra-Arterial
6
2019
59
0.860
Why?
Doxorubicin
9
2014
365
0.860
Why?
Uterine Artery Embolization
1
2023
7
0.860
Why?
Gallbladder Neoplasms
1
2023
23
0.850
Why?
Gastrointestinal Neoplasms
2
2019
77
0.840
Why?
Liver Regeneration
6
2017
46
0.840
Why?
Leiomyosarcoma
2
2022
28
0.830
Why?
Magnetic Resonance Spectroscopy
7
2022
616
0.830
Why?
Neoplasms
7
2021
2644
0.820
Why?
Antineoplastic Agents
9
2019
2129
0.810
Why?
Living Donors
4
2021
295
0.800
Why?
Adenocarcinoma
7
2020
936
0.800
Why?
Prospective Studies
29
2025
7583
0.780
Why?
Immunotherapy
2
2024
640
0.740
Why?
Hemangioma
4
2022
48
0.740
Why?
Patient Safety
1
2024
304
0.720
Why?
Fluorodeoxyglucose F18
3
2022
135
0.720
Why?
Renal Artery
2
2020
37
0.710
Why?
Inflammatory Bowel Diseases
2
2023
351
0.700
Why?
Meglumine
3
2018
18
0.700
Why?
Risk Assessment
11
2024
3429
0.690
Why?
Multidetector Computed Tomography
6
2024
39
0.680
Why?
Evidence-Based Medicine
12
2024
738
0.670
Why?
Cholangiopancreatography, Endoscopic Retrograde
2
2019
211
0.670
Why?
Obesity, Abdominal
1
2020
48
0.670
Why?
Adenocarcinoma, Mucinous
3
2018
80
0.670
Why?
Diffusion Tensor Imaging
2
2021
79
0.660
Why?
Catheter Ablation
8
2018
349
0.660
Why?
Subcutaneous Fat
1
2020
81
0.660
Why?
Vascular Diseases
2
2017
244
0.660
Why?
Necrosis
5
2021
244
0.650
Why?
Biomarkers, Tumor
8
2016
1274
0.630
Why?
Follow-Up Studies
20
2022
5115
0.620
Why?
Kidney
7
2025
1463
0.620
Why?
Observer Variation
8
2020
345
0.610
Why?
Young Adult
31
2024
13126
0.610
Why?
Radiology
6
2019
181
0.610
Why?
Gastrointestinal Stromal Tumors
1
2019
38
0.600
Why?
Adenoma, Oxyphilic
1
2018
7
0.590
Why?
Biliary Tract Diseases
4
2019
39
0.580
Why?
Hepatic Artery
3
2013
61
0.570
Why?
Niacinamide
3
2015
78
0.570
Why?
Neoplasms, Multiple Primary
1
2018
57
0.570
Why?
Phenylurea Compounds
3
2015
95
0.570
Why?
Angiography
4
2013
207
0.560
Why?
Biomarkers
9
2021
4158
0.550
Why?
Betacoronavirus
1
2020
267
0.550
Why?
Pancreatic Ducts
2
2015
85
0.550
Why?
Whole Body Imaging
3
2018
25
0.550
Why?
Defibrillators, Implantable
6
2022
315
0.550
Why?
Tachycardia, Ventricular
5
2022
174
0.540
Why?
Magnetic Resonance Imaging, Cine
5
2022
193
0.540
Why?
Early Detection of Cancer
9
2024
419
0.540
Why?
Actins
1
2019
415
0.540
Why?
Positron Emission Tomography Computed Tomography
4
2022
98
0.530
Why?
Lymph Nodes
5
2024
492
0.530
Why?
Cystadenoma, Mucinous
1
2016
13
0.520
Why?
Watchful Waiting
1
2016
80
0.500
Why?
Kaplan-Meier Estimate
11
2018
891
0.490
Why?
Heart Ventricles
8
2018
792
0.490
Why?
Adrenal Gland Neoplasms
1
2016
89
0.480
Why?
Liver Function Tests
3
2025
114
0.460
Why?
Radiographic Image Interpretation, Computer-Assisted
3
2025
107
0.460
Why?
Sarcopenia
6
2016
82
0.460
Why?
Leucovorin
2
2024
82
0.450
Why?
Choledochal Cyst
3
2022
19
0.450
Why?
Multimodal Imaging
3
2023
116
0.450
Why?
Bile Ducts
3
2019
71
0.440
Why?
Lupus Nephritis
2
2025
63
0.430
Why?
Neoplasm Recurrence, Local
7
2023
1055
0.430
Why?
Esophageal and Gastric Varices
2
2024
40
0.430
Why?
Neoplasm Invasiveness
4
2020
507
0.430
Why?
Fluorouracil
2
2024
210
0.420
Why?
Biliary Tract Neoplasms
1
2013
30
0.420
Why?
Survival Analysis
6
2019
1319
0.420
Why?
Aspartate Aminotransferases
1
2013
90
0.420
Why?
Choline
2
2011
131
0.410
Why?
Alanine Transaminase
1
2013
157
0.410
Why?
Proportional Hazards Models
10
2018
1260
0.400
Why?
Iron
3
2024
311
0.400
Why?
Organ Size
6
2019
477
0.400
Why?
Fatty Liver
4
2017
242
0.400
Why?
Death, Sudden, Cardiac
5
2022
184
0.400
Why?
Phantoms, Imaging
5
2021
151
0.390
Why?
Ventricular Fibrillation
3
2018
60
0.390
Why?
United States
28
2024
14660
0.390
Why?
Ventricular Function, Right
3
2020
283
0.390
Why?
Abdominal Pain
4
2023
145
0.390
Why?
Practice Guidelines as Topic
6
2024
1568
0.380
Why?
Abdomen
1
2013
125
0.380
Why?
Models, Biological
2
2016
1769
0.370
Why?
Authorship
1
2012
52
0.370
Why?
Risk Factors
23
2024
10331
0.370
Why?
Lupus Erythematosus, Systemic
2
2025
257
0.370
Why?
Area Under Curve
3
2019
313
0.370
Why?
Myocardial Perfusion Imaging
3
2025
40
0.370
Why?
Carcinoma in Situ
3
2021
49
0.360
Why?
Liver Neoplasms, Experimental
1
2011
31
0.360
Why?
Ethiodized Oil
3
2021
8
0.360
Why?
Endosonography
5
2020
156
0.350
Why?
Arrhythmias, Cardiac
5
2022
331
0.350
Why?
Cohort Studies
11
2024
5718
0.350
Why?
Cystadenoma
3
2023
6
0.350
Why?
Embolism
1
2011
41
0.350
Why?
Radiopharmaceuticals
4
2019
178
0.350
Why?
Echo-Planar Imaging
3
2023
21
0.340
Why?
Tomography, Spiral Computed
4
2007
32
0.340
Why?
Publishing
1
2012
146
0.340
Why?
Breast Neoplasms
6
2021
2239
0.340
Why?
Angiomatosis
1
2010
5
0.340
Why?
Radiologists
3
2024
50
0.330
Why?
Bevacizumab
3
2021
136
0.330
Why?
SEER Program
3
2024
218
0.330
Why?
Artificial Intelligence
3
2022
272
0.320
Why?
Myocardium
5
2018
1002
0.320
Why?
Disease Progression
7
2019
2750
0.320
Why?
Cystadenocarcinoma
2
2023
4
0.320
Why?
Periodicals as Topic
1
2012
210
0.320
Why?
Software
4
2018
663
0.320
Why?
Autoimmune Diseases
1
2013
459
0.310
Why?
Non-alcoholic Fatty Liver Disease
3
2021
278
0.310
Why?
Ventricular Dysfunction, Right
2
2025
236
0.310
Why?
Solitary Fibrous Tumors
1
2008
5
0.300
Why?
Secretin
3
2019
6
0.300
Why?
Eye Neoplasms
1
2008
18
0.300
Why?
Radiographic Image Enhancement
2
2012
58
0.290
Why?
Chi-Square Distribution
6
2017
532
0.280
Why?
Heart Atria
2
2018
136
0.280
Why?
Drug Delivery Systems
1
2011
362
0.280
Why?
Sentinel Surveillance
2
2018
47
0.270
Why?
Response Evaluation Criteria in Solid Tumors
2
2024
18
0.270
Why?
Rectum
3
2020
185
0.270
Why?
Leiomyomatosis
1
2007
6
0.270
Why?
Pancreatectomy
5
2020
252
0.270
Why?
Neovascularization, Pathologic
2
2008
301
0.260
Why?
Psoas Muscles
3
2015
13
0.260
Why?
Adolescent
16
2022
21463
0.260
Why?
Myocardial Contraction
2
2018
340
0.260
Why?
Ventricular Outflow Obstruction
2
2016
43
0.240
Why?
Models, Statistical
3
2019
658
0.240
Why?
Liver Failure
2
2016
94
0.230
Why?
Amyloidosis
1
2025
43
0.230
Why?
Disease Models, Animal
4
2020
4279
0.230
Why?
Proteinuria
1
2025
97
0.230
Why?
Collateral Circulation
1
2004
19
0.220
Why?
Cardiomyopathies
2
2025
350
0.220
Why?
Computed Tomography Angiography
1
2025
124
0.220
Why?
Biopsy
4
2025
1126
0.220
Why?
Scleroderma, Systemic
1
2025
122
0.220
Why?
Pancreas, Exocrine
1
2024
7
0.220
Why?
Rats, Sprague-Dawley
2
2020
2481
0.220
Why?
Protons
4
2020
90
0.220
Why?
Safety Management
1
2024
119
0.210
Why?
Atrial Fibrillation
2
2018
390
0.210
Why?
Hypertension, Portal
1
2004
64
0.210
Why?
Feasibility Studies
7
2024
947
0.210
Why?
Carcinoma, Papillary
2
2014
81
0.210
Why?
Hepatic Veins
1
2003
33
0.210
Why?
Cholecystitis, Acute
1
2023
23
0.200
Why?
Pulmonary Embolism
1
2025
220
0.200
Why?
Gastrointestinal Hemorrhage
1
2024
132
0.200
Why?
Colitis, Ulcerative
1
2024
135
0.200
Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
2023
56
0.200
Why?
Electrocardiography
4
2020
628
0.200
Why?
Pancreatitis, Chronic
2
2020
58
0.200
Why?
alpha-Fetoproteins
2
2013
46
0.200
Why?
Hemangioma, Cavernous
1
2022
15
0.200
Why?
Kasabach-Merritt Syndrome
1
2022
8
0.200
Why?
Cysts
1
2023
111
0.190
Why?
Statistics, Nonparametric
5
2019
430
0.190
Why?
Ultrasonography, Mammary
1
2021
13
0.180
Why?
Pandemics
2
2020
1619
0.180
Why?
Single-Blind Method
2
2017
286
0.180
Why?
National Institutes of Health (U.S.)
1
2022
128
0.180
Why?
Biomedical Research
2
2022
689
0.180
Why?
Nuclear Medicine
1
2021
9
0.180
Why?
Melanoma
1
2008
757
0.180
Why?
Time Factors
10
2018
6792
0.180
Why?
Semaphorins
1
2021
32
0.180
Why?
Portal Vein
4
2012
119
0.180
Why?
Rats
2
2020
5628
0.180
Why?
Awards and Prizes
1
2022
67
0.170
Why?
Crohn Disease
1
2024
242
0.170
Why?
Cholestasis
1
2023
232
0.170
Why?
Reference Values
2
2020
817
0.170
Why?
Maryland
3
2016
55
0.170
Why?
Cancer Care Facilities
1
2021
38
0.170
Why?
Margins of Excision
1
2020
50
0.170
Why?
Italy
1
2020
106
0.170
Why?
Kidney Cortex
1
2020
26
0.170
Why?
Inflammation
1
2011
2834
0.170
Why?
Regression Analysis
3
2018
1024
0.170
Why?
Rabbits
3
2011
789
0.170
Why?
Kidney Medulla
1
2020
35
0.170
Why?
Thorax
1
2020
47
0.170
Why?
Ferric Compounds
2
2012
55
0.170
Why?
Mammography
1
2021
151
0.170
Why?
Esophageal Mucosa
1
2020
22
0.160
Why?
Severity of Illness Index
4
2016
2831
0.160
Why?
Ursodeoxycholic Acid
1
2019
21
0.160
Why?
Digestive System Neoplasms
1
2019
9
0.160
Why?
Ultrasonography, Doppler, Color
1
2019
39
0.160
Why?
Cardiac-Gated Imaging Techniques
2
2016
21
0.160
Why?
Recurrence
2
2020
1058
0.160
Why?
Postoperative Complications
4
2016
2624
0.160
Why?
Jaundice
1
2019
14
0.160
Why?
Drug Therapy, Combination
3
2024
1059
0.160
Why?
Mutation
4
2015
3953
0.160
Why?
Pyridines
3
2021
505
0.160
Why?
Ovarian Neoplasms
1
2025
563
0.160
Why?
Microspheres
5
2016
137
0.150
Why?
Jejunum
1
2019
31
0.150
Why?
Benchmarking
1
2020
183
0.150
Why?
Elasticity
1
2019
197
0.150
Why?
Appendicitis
1
2000
130
0.150
Why?
Epidemiologic Methods
1
2019
96
0.150
Why?
Chronic Disease
4
2017
1784
0.150
Why?
Gadolinium
3
2021
82
0.150
Why?
Mucins
1
2019
73
0.150
Why?
Cardiac Imaging Techniques
2
2018
22
0.150
Why?
Vaccines
1
2024
406
0.150
Why?
Artifacts
2
2016
129
0.150
Why?
Atrophy
2
2020
184
0.150
Why?
Gastrointestinal Agents
1
2019
65
0.150
Why?
Brachytherapy
1
2019
119
0.150
Why?
Pericardium
1
2018
56
0.150
Why?
Viscera
1
2018
17
0.150
Why?
Prevalence
4
2023
2712
0.140
Why?
Animals
10
2020
36768
0.140
Why?
Equipment Safety
1
2017
37
0.140
Why?
Caloric Restriction
1
2019
123
0.140
Why?
Hemochromatosis
1
2017
10
0.140
Why?
Sepsis
1
2024
611
0.140
Why?
Combined Modality Therapy
5
2016
1235
0.140
Why?
Ventricular Flutter
1
2017
2
0.140
Why?
Disease Susceptibility
1
2019
344
0.140
Why?
Tomography, Emission-Computed
2
2010
66
0.140
Why?
Metastasectomy
1
2017
20
0.140
Why?
Pulmonary Veins
1
2018
99
0.130
Why?
Adrenocortical Adenoma
1
2016
2
0.130
Why?
Lymphography
1
2016
10
0.130
Why?
Lung
2
2020
4065
0.130
Why?
Breath Holding
1
2016
9
0.130
Why?
Obesity
3
2023
2975
0.130
Why?
Incidence
6
2020
2788
0.130
Why?
Electric Countershock
1
2017
107
0.130
Why?
Pacemaker, Artificial
1
2017
119
0.130
Why?
Evaluation Studies as Topic
1
2016
177
0.130
Why?
Motion
1
2016
98
0.130
Why?
Benzamides
1
2017
217
0.130
Why?
Body Water
1
2016
21
0.130
Why?
Coronary Circulation
2
2015
141
0.130
Why?
Primary Prevention
1
2018
196
0.130
Why?
Neoplasms, Second Primary
1
2017
115
0.130
Why?
Carcinoid Tumor
2
2008
26
0.120
Why?
Platelet Count
1
2016
86
0.120
Why?
Azacitidine
1
2017
141
0.120
Why?
Bariatric Surgery
1
2019
214
0.120
Why?
Adrenal Cortex Neoplasms
1
2016
63
0.120
Why?
Echocardiography
2
2016
659
0.120
Why?
Phosphorus
1
2016
97
0.120
Why?
Pancreatitis, Acute Necrotizing
1
2015
13
0.120
Why?
Fractures, Spontaneous
2
2005
15
0.120
Why?
Hepatopulmonary Syndrome
1
2015
25
0.120
Why?
Patient Care Team
1
2021
627
0.120
Why?
Adiposity
1
2020
518
0.120
Why?
Telomere Homeostasis
1
2015
33
0.120
Why?
Hospital Costs
1
2016
119
0.120
Why?
Bone Neoplasms
1
2018
248
0.120
Why?
Body Composition
1
2019
677
0.120
Why?
Preoperative Care
3
2024
356
0.120
Why?
Digestive System Surgical Procedures
1
2016
106
0.120
Why?
Telomere
2
2015
280
0.120
Why?
Hypertrophy, Left Ventricular
1
2016
130
0.120
Why?
Fractures, Stress
2
2005
35
0.120
Why?
Carcinoma, Squamous Cell
1
2020
682
0.120
Why?
Image-Guided Biopsy
1
2014
39
0.110
Why?
Disease-Free Survival
4
2022
687
0.110
Why?
Frail Elderly
1
2015
129
0.110
Why?
Consensus
1
2018
679
0.110
Why?
Acrylic Resins
2
2012
46
0.110
Why?
Biliary Tract
2
2012
17
0.110
Why?
Gelatin
2
2012
50
0.110
Why?
Antibiotics, Antineoplastic
2
2012
130
0.110
Why?
Critical Illness
1
2020
807
0.110
Why?
Gene Expression
1
2019
1499
0.110
Why?
Receptors, Vascular Endothelial Growth Factor
1
2014
108
0.110
Why?
Abdomen, Acute
1
2014
21
0.110
Why?
Cholecystitis
1
2014
24
0.110
Why?
Fissure in Ano
1
2013
4
0.110
Why?
Weight Loss
1
2019
775
0.110
Why?
Receptor, Angiotensin, Type 1
1
2013
25
0.110
Why?
Ventricular Remodeling
1
2016
262
0.110
Why?
Delayed-Action Preparations
1
2014
180
0.110
Why?
Multivariate Analysis
5
2017
1513
0.110
Why?
Linear Models
3
2011
845
0.110
Why?
Hypertension, Pulmonary
1
2025
1902
0.110
Why?
Tetrazoles
1
2013
40
0.100
Why?
Rectal Fistula
1
2013
27
0.100
Why?
Dyspnea
1
2015
251
0.100
Why?
Pattern Recognition, Automated
1
2013
73
0.100
Why?
Cystic Fibrosis
1
2023
1104
0.100
Why?
Carcinoma, Transitional Cell
2
2005
71
0.100
Why?
Analysis of Variance
2
2013
1318
0.100
Why?
Pelvic Neoplasms
1
2013
26
0.100
Why?
Academic Medical Centers
2
2013
497
0.100
Why?
Postoperative Period
3
2016
343
0.100
Why?
Abdominal Neoplasms
1
2013
39
0.100
Why?
Liver Circulation
1
2012
20
0.100
Why?
Endoscopy, Digestive System
2
2024
136
0.100
Why?
Logistic Models
3
2013
2060
0.100
Why?
Iohexol
1
2012
23
0.100
Why?
Radiography
5
2022
829
0.100
Why?
GTP-Binding Protein alpha Subunits, Gs
1
2012
11
0.100
Why?
Acute Disease
3
2023
1006
0.100
Why?
Polyvinyls
1
2012
20
0.100
Why?
Vascular Neoplasms
1
2012
18
0.100
Why?
Prednisone
1
2013
243
0.100
Why?
Ventricular Function, Left
1
2016
540
0.100
Why?
Imidazoles
1
2013
239
0.100
Why?
Electrophysiologic Techniques, Cardiac
3
2018
82
0.100
Why?
Computer Simulation
1
2016
973
0.090
Why?
Peer Review, Research
1
2012
43
0.090
Why?
DNA Methylation
1
2017
644
0.090
Why?
Genetic Predisposition to Disease
4
2013
2417
0.090
Why?
Bibliometrics
1
2012
60
0.090
Why?
Glucocorticoids
2
2013
596
0.090
Why?
Neoplastic Cells, Circulating
1
2012
80
0.090
Why?
Editorial Policies
1
2012
51
0.090
Why?
Intra-Abdominal Fat
2
2024
91
0.090
Why?
World Health Organization
2
2022
122
0.090
Why?
Myocardial Ischemia
1
2013
263
0.090
Why?
Angiogenesis Inhibitors
1
2012
226
0.090
Why?
Practice Patterns, Physicians'
3
2021
1294
0.090
Why?
Cell Transformation, Neoplastic
2
2024
326
0.090
Why?
Chemotherapy, Adjuvant
2
2024
390
0.090
Why?
Respiration
2
2017
197
0.080
Why?
Sclerosis
1
2010
13
0.080
Why?
Urinary Bladder
2
2022
185
0.080
Why?
Guidelines as Topic
1
2012
276
0.080
Why?
Dose-Response Relationship, Drug
1
2014
2045
0.080
Why?
Pituitary-Adrenal System
1
2011
162
0.080
Why?
Splenectomy
1
2010
62
0.080
Why?
Hypothalamo-Hypophyseal System
1
2011
197
0.080
Why?
Cell Proliferation
1
2017
2473
0.080
Why?
Saliva
1
2011
241
0.080
Why?
Ultrasonic Therapy
1
2009
15
0.080
Why?
Immunoglobulin G
1
2013
886
0.080
Why?
Pilot Projects
3
2019
1697
0.080
Why?
Exercise
2
2019
2038
0.080
Why?
Hydrocortisone
1
2011
317
0.080
Why?
Baltimore
3
2015
58
0.070
Why?
Lipids
1
2013
665
0.070
Why?
Brain
1
2020
2669
0.070
Why?
Stroke Volume
2
2022
619
0.070
Why?
Heart
3
2017
656
0.070
Why?
Organoplatinum Compounds
2
2019
46
0.070
Why?
Carcinoma, Islet Cell
1
2008
4
0.070
Why?
Internet
1
2012
648
0.070
Why?
Referral and Consultation
1
2013
777
0.070
Why?
Catheterization, Peripheral
1
2008
109
0.070
Why?
Intestinal Neoplasms
2
2004
29
0.070
Why?
Antibodies, Monoclonal, Humanized
1
2012
804
0.070
Why?
Circadian Rhythm
1
2011
465
0.070
Why?
Soft Tissue Neoplasms
1
2008
114
0.070
Why?
Duodenum
2
2019
77
0.060
Why?
Cross-Sectional Studies
4
2022
5417
0.060
Why?
Radiotherapy
1
2006
201
0.060
Why?
Uterus
1
2007
215
0.060
Why?
Minimally Invasive Surgical Procedures
1
2007
181
0.060
Why?
Gallbladder Diseases
1
2005
12
0.060
Why?
Edetic Acid
1
2005
50
0.060
Why?
Sus scrofa
2
2016
52
0.060
Why?
Pyridoxal Phosphate
1
2005
24
0.060
Why?
Iodized Oil
3
2012
4
0.060
Why?
Case-Control Studies
3
2019
3537
0.060
Why?
Splenic Vein
1
2004
1
0.060
Why?
Portography
1
2004
12
0.060
Why?
Portal System
1
2004
14
0.060
Why?
Mesenteric Vascular Occlusion
1
2004
6
0.060
Why?
Myometrium
1
2005
39
0.060
Why?
Receptors, Somatostatin
1
2004
25
0.060
Why?
Somatostatin
1
2004
61
0.060
Why?
Mesenteric Veins
1
2004
22
0.050
Why?
Age Factors
3
2018
3290
0.050
Why?
Arteriosclerosis
1
2004
88
0.050
Why?
Calibration
1
2024
145
0.050
Why?
Body Mass Index
3
2019
2364
0.050
Why?
Ovary
1
2025
221
0.050
Why?
Peripheral Vascular Diseases
1
2004
103
0.050
Why?
Ipilimumab
1
2023
33
0.050
Why?
Constriction, Pathologic
1
2004
241
0.050
Why?
Carcinosarcoma
1
2003
21
0.050
Why?
Pelvis
1
2024
112
0.050
Why?
Mycophenolic Acid
1
2024
117
0.050
Why?
Creatinine
1
2025
498
0.050
Why?
Common Bile Duct
1
2022
17
0.050
Why?
Intestine, Small
1
2004
154
0.050
Why?
Ventricular Dysfunction, Left
1
2006
389
0.050
Why?
Heart Aneurysm
1
2002
11
0.050
Why?
Registries
3
2018
2015
0.050
Why?
X-Rays
1
2022
29
0.050
Why?
Kinetics
2
2017
1668
0.050
Why?
Financing, Organized
1
2022
35
0.050
Why?
Financing, Government
1
2022
46
0.050
Why?
Heart Failure
1
2015
2228
0.050
Why?
Hormones
1
2022
142
0.050
Why?
Aorta, Thoracic
1
2004
267
0.050
Why?
Morbidity
2
2013
322
0.050
Why?
B7-H1 Antigen
1
2023
217
0.040
Why?
Consensus Development Conferences as Topic
1
2021
28
0.040
Why?
Anilides
1
2021
73
0.040
Why?
Research Support as Topic
1
2022
118
0.040
Why?
Fluoroscopy
1
2021
157
0.040
Why?
Pedigree
2
2012
514
0.040
Why?
Patient Selection
2
2017
689
0.040
Why?
Cholinergic Agents
1
2020
18
0.040
Why?
Breast
1
2021
150
0.040
Why?
Mitomycin
2
2012
34
0.040
Why?
Length of Stay
2
2016
1208
0.040
Why?
Monitoring, Physiologic
1
2002
267
0.040
Why?
Disease Management
2
2014
623
0.040
Why?
Preoperative Period
1
2020
130
0.040
Why?
Aorta
1
2023
417
0.040
Why?
Appendectomy
1
2000
79
0.040
Why?
Islets of Langerhans Transplantation
1
2020
64
0.040
Why?
Precision Medicine
1
2024
426
0.040
Why?
Cachexia
1
2020
71
0.040
Why?
Emergencies
1
2000
164
0.040
Why?
Hepatitis C
1
2002
263
0.040
Why?
Gastroplasty
1
2019
30
0.040
Why?
Surveys and Questionnaires
1
2012
5749
0.040
Why?
Pancreatic Function Tests
1
2019
4
0.040
Why?
Data Accuracy
1
2019
63
0.040
Why?
Longitudinal Studies
2
2018
2847
0.040
Why?
Immunosuppressive Agents
1
2024
890
0.040
Why?
Absorptiometry, Photon
1
2019
253
0.040
Why?
Risk
1
2021
904
0.040
Why?
Cisplatin
2
2012
318
0.040
Why?
Gastric Bypass
1
2019
118
0.040
Why?
Paclitaxel
1
2019
227
0.030
Why?
Electric Power Supplies
1
2017
52
0.030
Why?
Neoplasm Metastasis
2
2012
654
0.030
Why?
Global Health
1
2020
386
0.030
Why?
Equipment Failure
1
2017
108
0.030
Why?
Infant
3
2022
9442
0.030
Why?
HCT116 Cells
1
2017
80
0.030
Why?
Hemorrhage
1
2022
723
0.030
Why?
Child
4
2023
21968
0.030
Why?
Camptothecin
1
2017
114
0.030
Why?
Electrocardiography, Ambulatory
1
2017
63
0.030
Why?
Zinc Finger Protein Gli3
1
2016
3
0.030
Why?
Pain
1
2022
755
0.030
Why?
Xenopus Proteins
1
2016
37
0.030
Why?
Radionuclide Imaging
2
2008
118
0.030
Why?
Databases, Factual
2
2016
1347
0.030
Why?
Glomerular Filtration Rate
1
2020
744
0.030
Why?
Machine Learning
1
2021
487
0.030
Why?
Intensive Care Units
1
2022
802
0.030
Why?
Exudates and Transudates
1
2015
13
0.030
Why?
Equipment Failure Analysis
1
2016
132
0.030
Why?
Phenotype
2
2015
3199
0.030
Why?
Advisory Committees
1
2017
219
0.030
Why?
Cell Line, Tumor
2
2017
3399
0.030
Why?
Echocardiography, Stress
1
2015
25
0.030
Why?
Species Specificity
1
2016
584
0.030
Why?
Drug Administration Schedule
1
2017
783
0.030
Why?
Models, Animal
1
2016
384
0.030
Why?
Heterozygote
1
2015
292
0.030
Why?
Sex Factors
2
2015
2068
0.030
Why?
Clinical Decision-Making
1
2017
318
0.030
Why?
Equipment Design
1
2016
522
0.030
Why?
Delivery of Health Care
1
2021
939
0.030
Why?
Biomechanical Phenomena
1
2017
808
0.030
Why?
Geriatric Assessment
1
2015
218
0.030
Why?
Compressive Strength
1
2014
73
0.030
Why?
Autoradiography
1
2013
78
0.030
Why?
Injections, Intra-Arterial
1
2013
27
0.030
Why?
Blood Cell Count
1
2013
54
0.030
Why?
Anaplasia
1
2013
6
0.030
Why?
Epithelial Cells
1
2020
1093
0.030
Why?
Netherlands
1
2013
88
0.030
Why?
Fractional Flow Reserve, Myocardial
1
2013
9
0.030
Why?
Radiology, Interventional
1
2013
33
0.030
Why?
Pressure
1
2014
222
0.030
Why?
Telomerase
1
2015
250
0.030
Why?
Molecular Imaging
1
2013
55
0.030
Why?
Cicatrix
1
2013
64
0.030
Why?
Pancreatic Juice
1
2012
2
0.020
Why?
Chromogranins
1
2012
15
0.020
Why?
Chemoradiotherapy, Adjuvant
1
2012
43
0.020
Why?
Microcirculation
1
2013
145
0.020
Why?
Epigenesis, Genetic
1
2017
658
0.020
Why?
Heredity
1
2012
13
0.020
Why?
In Situ Hybridization, Fluorescence
1
2013
317
0.020
Why?
DNA, Neoplasm
1
2012
164
0.020
Why?
Bilirubin
1
2012
97
0.020
Why?
Benzenesulfonates
1
2011
22
0.020
Why?
China
1
2012
217
0.020
Why?
Hepatitis B, Chronic
1
2011
23
0.020
Why?
Asymptomatic Diseases
1
2012
87
0.020
Why?
Treatment Failure
1
2012
353
0.020
Why?
Antibiotic Prophylaxis
1
2012
117
0.020
Why?
Ligands
1
2013
664
0.020
Why?
Allostasis
1
2011
17
0.020
Why?
Europe
1
2012
414
0.020
Why?
Early Diagnosis
1
2012
243
0.020
Why?
General Surgery
1
2013
169
0.020
Why?
Adrenal Glands
1
2011
77
0.020
Why?
Gastroenterology
1
2013
181
0.020
Why?
Vasodilator Agents
1
2013
331
0.020
Why?
Canada
1
2012
420
0.020
Why?
Medical Oncology
1
2013
290
0.020
Why?
Action Potentials
1
2013
495
0.020
Why?
Molecular Targeted Therapy
1
2012
413
0.020
Why?
Sodium Isotopes
1
2009
2
0.020
Why?
Hepatitis C, Chronic
1
2011
163
0.020
Why?
Neoplasm Proteins
1
2012
432
0.020
Why?
Dexamethasone
1
2011
377
0.020
Why?
Immunohistochemistry
1
2013
1731
0.020
Why?
Hemodynamics
1
2013
1110
0.020
Why?
Thrombosis
1
2012
367
0.020
Why?
Tissue Distribution
1
2008
329
0.020
Why?
Femoral Artery
1
2007
179
0.020
Why?
Blood Glucose
1
2016
2180
0.020
Why?
Mass Screening
1
2014
1262
0.020
Why?
Child, Preschool
2
2014
11069
0.020
Why?
Gallbladder
1
2005
19
0.010
Why?
Tissue Survival
1
2005
17
0.010
Why?
Diabetes Mellitus, Type 2
1
2019
2512
0.010
Why?
Indium Radioisotopes
1
2004
14
0.010
Why?
Adenoma, Islet Cell
1
2004
8
0.010
Why?
Bone Diseases
1
2005
62
0.010
Why?
Radiography, Interventional
1
2005
114
0.010
Why?
Mice
1
2020
17731
0.010
Why?
Aneurysm, False
1
2002
48
0.010
Why?
Research Design
1
2007
1107
0.010
Why?
Palliative Care
1
2005
743
0.010
Why?
Myocardial Infarction
1
2002
1045
0.010
Why?
Kamel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)